{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:25:03Z","timestamp":1775085903923,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate and compare the pattern of resistance to topical moxifloxacin of ocular isolates recovered during comparable periods within 2 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Records of 611 consecutive cases of bacterial corneal ulcers that presented to our center between April and August 2007 were compared with records of 417 cases that presented in April and August 2006. Records of culture and sensitivity to cefazolin, tobramycin, gatifloxacin, and moxifloxacin at the time of presentation were analyzed. Parameters recorded included total number of cases in each period, culture\u2010positive cases, organisms isolated, and sensitivity by Kirby\u2010Bauer disk\u2010diffusion test. The data from 2007 was compared with those from 2006 using\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Culture\u2010positive rate was 70.2% in 2007 compared with 65.0% in 2006 (p = 0.143). The percentage of culture\u2010positive cases resistant to moxifloxacin was 5.46% in 2007 compared with 5.42% in 2006 (p = 0.977). There was no significant difference between resistance against cefazolin during the two periods (p = 0.895). Resistance to gatifloxacin and tobramycin was significantly higher in samples tested in 2007 as compared with those tested in 2006 (gatifloxacin, p = 0.037; tobramycin, p = 0.031).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Resistance to moxifloxacin did not change significantly during a period of 2 years in our study. The static resistance pattern to moxifloxacin may indicate that such resistance to moxifloxacin is intrinsic in the antibiotic rather than new resistance stemming from mutations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/opx.0b013e31827717d4","type":"journal-article","created":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T02:12:19Z","timestamp":1352427139000},"page":"1721-1724","source":"Crossref","is-referenced-by-count":6,"title":["Moxifloxacin Resistance"],"prefix":"10.1002","volume":"89","author":[{"given":"Tushar","family":"Agarwal","sequence":"first","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Jhanji","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences The Chinese University of Hong Kong Hong Kong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Satpathy","sequence":"additional","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan","family":"Nayak","sequence":"additional","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavna","family":"Chawla","sequence":"additional","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Tandon","sequence":"additional","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeewan S.","family":"Titiyal","sequence":"additional","affiliation":[{"name":"R.P. Centre for Ophthalmic Sciences All India Institute of Medical Sciences New Delhi India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jcrs.2010.06.028","article-title":"Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones","volume":"36","author":"McDonald M","year":"2010","journal-title":"J Cataract Refract Surg"},{"key":"e_1_2_6_3_1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/archopht.124.4.479","article-title":"In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates","volume":"124","author":"Miller D","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3928\/15428877-20071101-01","article-title":"Endophthalmitis caused by Staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes","volume":"38","author":"Miller DM","year":"2007","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/112067211002000207","article-title":"In vitro susceptibility of bacterial keratitis isolates to fourth\u2010generation fluoroquinolones","volume":"20","author":"Chawla B","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"Bauer AW","year":"1966","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"e_1_2_6_7_1","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: mechanism of action, classification, and development of resistance","volume":"49","author":"Blondeau JM","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jac\/dkn528","article-title":"Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae,\n                  Staphylococcus aureus and Escherichia coli.","volume":"63","author":"Cambau E","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"e_1_2_6_9_1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.survophthal.2004.01.004","article-title":"Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones","volume":"49","author":"Hwang DG","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000084270","article-title":"Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics","volume":"37","author":"Kaliamurthy J","year":"2005","journal-title":"Ophthalmic Res"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram\u2010negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser MM","year":"2003","journal-title":"JAMA"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1167\/iovs.09-4638","article-title":"Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis","volume":"51","author":"Sueke H","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study","volume":"152","author":"Haas W","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jinf.2004.03.007","article-title":"Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001\/2002","volume":"49","author":"Morrissey I","year":"2004","journal-title":"J Infect"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/44.5.621","article-title":"Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin","volume":"44","author":"Pong A","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth\u2010generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics","volume":"133","author":"Mather R","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jcrs.2004.06.048","article-title":"Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing","volume":"30","author":"Levine JM","year":"2004","journal-title":"J Cataract Refract Surg"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31827717d4","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/OPX.0b013e31827717d4","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31827717d4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:59:21Z","timestamp":1774951161000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/OPX.0b013e31827717d4"}},"subtitle":["Intrinsic to Antibiotic or Related to Mutation?"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1097\/OPX.0b013e31827717d4"],"URL":"https:\/\/doi.org\/10.1097\/opx.0b013e31827717d4","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}